Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Discovering Novel Cancer Treatment Options Using a Comprehensive NGS-based Liquid Molecular Testing Panel in the Community Setting. ("DINOSAur II")

NCT05703243 is registered in ClinicalTrials.gov with Glendale Adventist Medical Center d/b/a Adventist Health Glendale as lead sponsor.

NCT NCT05703243
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05703243 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Discovering Novel Cancer Treatment Options Using a Comprehensive NGS-based Liquid Molecular Testing Panel in the Community Setting. ("DINOSAur II")
Lead sponsor
Glendale Adventist Medical Center d/b/a Adventist Health Glendale
Phase
Observational
Overall status
Unknown status
Start date
February 1, 2023
Completion date
January 1, 2025
Enrollment
572 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage iii solid tumors, stage iv solid tumors